Compare MPB & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPB | BLFS |
|---|---|---|
| Founded | 1868 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.0M | 923.5M |
| IPO Year | 1996 | 2013 |
| Metric | MPB | BLFS |
|---|---|---|
| Price | $32.71 | $25.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $37.00 | $32.00 |
| AVG Volume (30 Days) | 107.3K | ★ 519.2K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | ★ 0.36 | 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $30.95 | $19.73 |
| Revenue Next Year | $9.45 | $17.82 |
| P/E Ratio | ★ $90.72 | $1,273.75 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $25.83 | $17.86 |
| 52 Week High | $35.22 | $29.57 |
| Indicator | MPB | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 50.68 | 66.04 |
| Support Level | $30.66 | $23.74 |
| Resistance Level | $34.88 | $26.39 |
| Average True Range (ATR) | 0.77 | 1.10 |
| MACD | 0.10 | 0.28 |
| Stochastic Oscillator | 78.30 | 87.16 |
Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.